Reduced myocardial 18F-FDG uptake after calcium channel blocker administration. Initial observation for a potential new method to improve plaque detection

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 11, 2011, Pages 2018-2024

  Gaeta, Chiara ^a   Fernández, Yolanda ^b   Pavía, Javier ^b,c   Flotats, Albert ^a   Artigas, Carles ^a   Deportos, Jordi ^a   Geraldo, Llanos ^a   Carrió, Ignasi ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b CETIR   (Spain)

^c BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

18F FDG; Calcium channel blocker; Coronary atherosclerosis; Mice; PET

Indexed keywords

CALCIUM; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; VERAPAMIL; CALCIUM CHANNEL BLOCKING AGENT; DIAGNOSTIC AGENT;

ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; GLUCOSE TRANSPORT; HEART MUSCLE; IMAGE ANALYSIS; IMAGE QUALITY; MALE; MOUSE; NONHUMAN; PREMEDICATION; PROCESS OPTIMIZATION; SINGLE DRUG DOSE; ANIMAL; ATHEROSCLEROTIC PLAQUE; C57BL MOUSE; DRUG EFFECT; METABOLISM; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM CHANNEL BLOCKERS; FLUORODEOXYGLUCOSE F18; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; VERAPAMIL;

EID: 80255124843     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1873-2     Document Type: Article

References (24)

1. JH Rudd EA Warburton TD Fryer HA Jones JC Clark N Antoun, et al. 2002 Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography Circulation 105 2708 2711 12057982 10.1161/01.CIR.0000020548.60110.76 1:STN:280:DC%2BD38zhsFCisg%3D%3D (Pubitemid 34615139)
2. A Tawakol RQ Migrino GG Bashian S Bedri D Vermylen RC Cury, et al. 2006 In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients J Am Coll Cardiol 48 1818 1824 17084256 10.1016/j.jacc.2006.05.076 (Pubitemid 44648622)
3. JH Rudd J Narula HW Strauss R Virmani J Machac M Klimas, et al. 2010 Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol 55 2527 2535 20513592 10.1016/j.jacc.2009.12.061
4. AV Finn M Nakano J Narula FD Kolodgie R Virmani 2010 Concept of vulnerable/unstable plaque Arterioscler Thromb Vasc Biol 30 1282 1292 20554950 10.1161/ATVBAHA.108.179739 1:CAS:528:DC%2BC3cXnsFGgt78%3D
5. C Depre JL Vanoverschelde H Taegtmeyer 1999 Glucose for the heart Circulation 99 578 588 9927407 1:CAS:528:DyaK1MXht1Gnsro%3D (Pubitemid 29061876)
6. Hardman JG, Limbird LE, Gilman AG. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw-Hill; 2001. p. 853-60.
7. BJ Fueger J Czernin I Hildebrandt C Tran BS Halpern D Stout, et al. 2006 Impact of animal handling on the results of 18F-FDG PET studies in mice J Nucl Med 47 999 1006 16741310 1:CAS:528:DC%2BD28XmtlWmtrk%3D (Pubitemid 46939953)
8. KP Wong W Sha X Zhang SC Huang 2011 Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice J Nucl Med 52 5 800 807 21498533 10.2967/jnumed.110.085092
9. Y Wang J Seidel BM Tsui JJ Vaquero MG Pomper 2006 Performance evaluation of GE Healthcare eXplore VISTA dual-ring small-animal PET scanner J Nucl Med 47 1891 1900 17079824 (Pubitemid 47545013)
10. PD Acton KJ Friston 1998 Statistical parametric mapping in functional neuroimaging: beyond PET and fMRI activation studies Eur J Nucl Med 25 663 667 9741993 1:STN:280:DyaK1cvgsFaltg%3D%3D (Pubitemid 28377027)
11. C Rorden M Brett 2000 Stereotaxic display of brain lesions Behav Neurol 12 191 200 11568431 (Pubitemid 32843166)
12. T Björnheden M Levin M Evaldsson O Wiklund 1999 Evidence of hypoxic areas within the arterial wall in vivo Arterioscler Thromb Vasc Biol 19 870 876 10195911 10.1161/01.ATV.19.4.870 (Pubitemid 29177331)
13. M Mayr A Sidibe A Zampetaki 2008 The paradox of hypoxic and oxidative stress in atherosclerosis J Am Coll Cardiol 51 1266 1267 18371556 10.1016/j.jacc.2008.01.005 (Pubitemid 351400902)
14. O Leppänen T Björnheden M Evaldsson J Borén O Wiklund M Levin 2006 ATP depletion in macrophages in the core of advanced rabbit atherosclerotic plaques in vivo Atherosclerosis 188 323 330 16405894 10.1016/j.atherosclerosis.2005.11.017 (Pubitemid 44301139)
15. HW Strauss M Dunphy N Tokita 2004 Imaging the vulnerable plaque: a scintillating light at the end of the tunnel? J Nucl Med 45 1106 1107 15235054 1:CAS:528:DC%2BD2cXnsFygsLo%3D (Pubitemid 47611654)
16. O Israel M Weiler-Sagie S Rispler R Bar-Shalom A Frenkel Z Keidar, et al. 2007 PET/CT quantitation of the effect of patient-related factors on cardiac 18F-FDG uptake J Nucl Med 48 234 239 17268020 1:CAS:528:DC%2BD2sXjsVKmsbw%3D (Pubitemid 47555349)
17. MP Dunphy A Freiman SM Larson HW Strauss 2005 Association of vascular 18F-FDG uptake with vascular calcification J Nucl Med 46 1278 1284 16085583 (Pubitemid 43733476)
18. EJ Fine W Miao W Koba JS Volek MD Blaufox 2009 Chronic effects of dietary carbohydrate variation on [18F]-2-fluoro-2-deoxyglucose uptake in rodent heart Nucl Med Commun 30 675 680 19525881 10.1097/MNM.0b013e32832aa6e8 1:CAS:528:DC%2BD1MXhtV2iurvL
19. G Williams GM Kolodny 2008 Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet AJR Am J Roentgenol 190 W151 W156 18212199 10.2214/AJR.07.2409
20. VY Cheng PJ Slomka M Ahlen LE Thomson AD Waxman DS Berman 2010 Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: a randomized controlled trial J Nucl Cardiol 17 2 286 291 20013165 10.1007/s12350-009-9179-5
21. J Wykrzykowska S Lehman G Williams JA Parker MR Palmer S Varkey, et al. 2009 Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation J Nucl Med 50 563 568 19289431 10.2967/jnumed.108.055616
22. PJ Randle PB Garland CN Hales EA Newsholme 1963 The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus Lancet 1 785 789 13990765 10.1016/S0140-6736(63)91500-9 1:STN:280:DyaF387ot1KhsQ%3D%3D
23. C Depre S Ponchaut J Deprez L Maisin L Hue 1998 Cyclic AMP suppresses the inhibition of glycolysis by alternative oxidizable substrates in the heart J Clin Invest 101 390 397 9435311 10.1172/JCI1168 1:CAS:528:DyaK1cXmtF2itQ%3D%3D (Pubitemid 28067336)
24. JG Dobson Jr J Ross Jr SE Mayer 1976 The role of cyclic adenosine 3′,5′-monophosphate and calcium in the regulation of contractility and glycogen phosphorylase activity in guinea pig papillary muscle Circ Res 39 388 395 182412 1:CAS:528:DyaE28XlsVSlsrg%3D